Necrosis-like cell death modes in heart failure: the influence of aetiology and the effects of RIP3 inhibition
Basic Research in Cardiology · 15.03.2025 · 120 (2) · 373-392
DOI: 10.1007/s00395-025-01101-4 ↗Kurz gefasst
Fachartikel in der Zeitschrift Basic Research in Cardiology, online erschienen am 15.03.2025. Verfasst von Izabela Jarabicová und 17 weiteren Autor:innen. Beteiligte Einrichtung: Faculty of Pharmacy, Department of Pharmacology and Toxicology, Comenius University, Odbojárov 10, 832 32, Bratislava, Slovak Republic. Hauptthemen laut MEDLINE: Receptor-Interacting Protein Serine-Threonine Kinases, Heart Failure, Necroptosis, Pyroptosis. Die Arbeit wurde bisher 18-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Agentúra na Podporu Výskumu a Vývoja, Agentura Pro Zdravotnický Výzkum České Republiky, National Institute for Research of Metabolic and Cardiovascular Diseases, Programme EXCELES.
Themen: Herzinsuffizienz
Abstract (Originalsprache)
Since cell dying in heart failure (HF) may vary based on the aetiology, we examined the main forms of regulated necrosis, such as necroptosis and pyroptosis, in the hearts damaged due to myocardial infarction (MI) or pressure overload. We also investigated the effects of a drug inhibiting RIP3, a proposed convergent point for both these necrosis-like cell death modes. In rat hearts, left ventricular function, remodelling, pro-cell death, and pro-inflammatory events were investigated, and the pharmacodynamic action of RIP3 inhibitor (GSK'872) was assessed. Regardless of the HF aetiology, the heart cells were dying due to necroptosis, albeit the upstream signals may be different. Pyroptosis was observed only in post-MI HF. The dysregulated miRNAs in post-MI hearts were accompanied by higher levels of a predicted target, HMGB1, its receptors (TLRs), as well as the exacerbation of inflammation likely originating from macrophages. The RIP3 inhibitor suppressed necroptosis, unlike pyroptosis, normalised the dysregulated miRNAs and tended to decrease collagen content and affect macrophage infiltration without affecting cardiac function or structure. The drug also mitigated the local heart inflammation and normalised the higher circulating HMGB1 in rats with post-MI HF. Elevated serum levels of HMGB1 were also detected in HF patients and positively correlated with C-reactive protein, highlighting pro-inflammatory axis. In conclusion, in MI-, but not pressure overload-induced HF, both necroptosis and pyroptosis operate and might underlie HF pathogenesis. The RIP3-targeting pharmacological intervention might protect the heart by preventing pro-death and pro-inflammatory mechanisms, however, additional strategies targeting multiple pro-death pathways may exhibit greater cardioprotection.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Faculty of Pharmacy, Department of Pharmacology and Toxicology, Comenius University, Odbojárov 10, 832 32, Bratislava, Slovak Republic.
- Institute of Physiology, Czech Academy of Sciences, Prague, Czech Republic.
- First Faculty of Medicine, Institute of Anatomy, Charles University, Prague, Czech Republic.
- Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
- Institute of Biotechnology, Czech Academy of Sciences, Prague, Czech Republic.
- Faculty of Natural Sciences, Department of Animal Physiology and Ethology, Comenius University, Bratislava, Slovak Republic.
Förderung
- Agentúra na Podporu Výskumu a Vývoja
- Agentura Pro Zdravotnický Výzkum České Republiky
- National Institute for Research of Metabolic and Cardiovascular Diseases, Programme EXCELES
- European Union - Next generation EU
- Ministerstvo Zdravotnictví Ceské Republiky
- Comenius University in Bratislava
Zitieren
APA
Jarabicová, I., Horváth, C., Hrdlička, J., Boroš, A., Olejníčková, V., Zábrodská, E., Hubáčková, S. Š., Šutovská, H. M., Molčan, Ľ., Kopkan, L., Chudý, M., Kura, B., Kaločayová, B., Goncalvesová, E., Neckář, J., Zeman, M., Kolář, F., & Adameová, A. (2025). Necrosis-like cell death modes in heart failure: the influence of aetiology and the effects of RIP3 inhibition. Basic Research in Cardiology, 120(2), 373-392. https://doi.org/10.1007/s00395-025-01101-4
Vancouver
Jarabicová I, Horváth C, Hrdlička J, Boroš A, Olejníčková V, Zábrodská E, et al. Necrosis-like cell death modes in heart failure: the influence of aetiology and the effects of RIP3 inhibition. Basic Research in Cardiology. 2025;120(2):373-392. doi:10.1007/s00395-025-01101-4
BibTeX
@article{Jarabicov2025,
author = {Jarabicová, Izabela and Horváth, Csaba and Hrdlička, Jaroslav and Boroš, Almos and Olejníčková, Veronika and Zábrodská, Eva and Hubáčková, Soňa Štemberková and Šutovská, Hana Mauer and Molčan, Ľuboš and Kopkan, Libor and Chudý, Martin and Kura, Branislav and Kaločayová, Barbora and Goncalvesová, Eva and Neckář, Jan and Zeman, Michal and Kolář, František and Adameová, Adriana},
title = {Necrosis-like cell death modes in heart failure: the influence of aetiology and the effects of RIP3 inhibition},
journal = {Basic Research in Cardiology},
year = {2025},
volume = {120},
number = {2},
pages = {373--392},
doi = {10.1007/s00395-025-01101-4}
}
EUVIMED